Riskpilot← Back to searchSign inGet full accessOrexo AB
ABActiveOrg 5565000600Virdings Allé 22Research and experimental development on natural sciences and engineering · NACE 7210Est. 199456 employees
Revenue 2024
SEK 304M
-38% vs 2023
EBITDA margin
300.0%
+2324% vs 2023
Equity ratio
66.3%
Financial strength
Net profit 2024
SEK 865M
+1336% vs 2023
| Revenue | SEK 304M | -38% |
| EBITDA | SEK 912M | +2324% |
| Net profit | SEK 865M | +1336% |
| Total assets | SEK 1,6B | +91% |
| Equity | SEK 1B | +534% |
| Employees | 56 | — |
Legal name
Orexo AB
Org number
5565000600
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
25 november 1994
Share capital
SEK 14 000 000
Employees
56 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas var för sig av externa firmatecknarna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget har till föremål för sin verksamhet att, direkt eller indirekt, bedriva forskning och utveckling, tillverkning, marknadsföring och försäljning av läkemedel och diagnostiska beredningar, att förvalta fast och lös egendom samt att bedriva annan därmed förenlig verksamhet.
Address
Virdings Allé 22
Phone
+46187808800
Email
info@orexo.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 408 000 | 534 000 | 446 000 | 366 000 | 348 000 | 494 000 | 304 000 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −89 820 | −56 700 | 63 300 | 58 000 | 238 000 | −7 000 | −214 000 | −214 000 | −41 000 | 912 000 |
| Depreciation & amort. | — | — | — | — | — | — | — | — | — | — |
| EBIT | −89 820 | −56 700 | 63 300 | 58 000 | 238 000 | −7 000 | −214 000 | −214 000 | −41 000 | 912 000 |
| Net financials | −71 970 | −39 100 | −28 200 | −6 000 | −7 000 | −16 000 | −32 000 | 17 000 | −29 000 | −46 000 |
| Profit before tax | −161 790 | −95 800 | 35 100 | 52 000 | 231 000 | −24 000 | −220 000 | −197 000 | −70 000 | 865 000 |
| Tax | −481 | −0 | 7 600 | 53 000 | −12 000 | −49 000 | −0 | −0 | −0 | −0 |
| Net profit | −162 271 | −95 800 | 42 700 | 105 000 | 219 000 | −73 000 | −220 000 | −197 000 | −70 000 | 865 000 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 042 854 | 867 600 | 858 800 | 962 000 | 1 137 000 | 1 006 000 | 1 070 000 | 878 000 | 810 000 | 1 550 000 |
| Equity | 353 356 | 263 500 | 309 400 | 417 000 | 644 000 | 524 000 | 306 000 | 109 000 | 162 000 | 1 027 000 |
| Long-term debt | 494 334 | 399 100 | 319 100 | 321 000 | 297 000 | 25 000 | 492 000 | 495 000 | 459 000 | 482 000 |
| Short-term debt | 191 250 | 205 000 | 225 400 | 220 000 | 195 000 | 457 000 | 259 000 | 265 000 | 188 000 | 40 000 |
| Total debt | 685 584 | 604 100 | 544 500 | 541 000 | 492 000 | 482 000 | 751 000 | 760 000 | 647 000 | 522 000 |
EBITDA margin
300.0%
This company
15.8%
Market median
+1799% vs market
20152024
Equity ratio
66.3%
This company
38.2%
Market median
+74% vs market
20152024
Return on equity
84.2%
This company
18.4%
Market median
+358% vs market
20152024
Net profit margin
284.5%
This company
8.1%
Market median
+3412% vs market
20152024
Asset turnover
0.20×
This company
1.12×
Market median
-82% vs market
20152024
Debt / equity
0.51×
This company
0.62×
Market median
+18% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
EO Chief Auditor | Chief Auditor | 2021 | — | — |
JN External Signatory | External Signatory | 2020 | — | — |
JA External Signatory | External Signatory | 2022 | — | — |
JA External Signatory | External Signatory | 2022 | — | — |
JA External Signatory | External Signatory | 2022 | — | — |
BS Chief Auditor | Chief Auditor | 2020 | — | — |
PF External Signatory | External Signatory | 2020 | — | — |
NA Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
AK Chief Auditor | Chief Auditor | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Orexo AB (this company)
OREXO PHARMACEUTICALS INCBoard members of Orexo AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Oskar Wall | Chief Auditor | 0 companies |
| Johannes Nikolaus Doll | External Signatory | 0 companies |
| Janne Antti Laine | External Signatory | 0 companies |
| Joseph Anthony De Feo | External Signatory | 0 companies |
| Joseph Anthony De Feo | External Signatory | 0 companies |
| Björn Sture Bernhard Peters Ohlsson | Chief Auditor | 0 companies |
| Per Fredrik Järrsten | External Signatory | 0 companies |
| Nikolaj Arrild Sörensen | Chief Executive Officer | 0 companies |
| Anna Kristina Svanberg | Chief Auditor | 0 companies |
| Maria Christina P Schauman | Board of Directors | 0 companies |
| Alf Gunnar Martin Nicklasson | Chairman | 0 companies |
| Friedrich Harald von Bohlen und Halbach | Chairman | 0 companies |
| Robin Paul Evers | Board of Directors | 0 companies |
| George Frederick Wilkinsson | Board of Directors | 0 companies |
| Nina Charlotte Hansson | Board of Directors | 0 companies |
| Mary Patricia Christie | Board of Directors | 0 companies |
| Henrik Kjær Hansen | Board of Directors | 0 companies |
| Kirsten Hegan Detrick | Board of Directors | 0 companies |
| James Julian Noble | Chairman | 0 companies |
| David Colpman | Board of Directors | 0 companies |
| Christine Elizabeth Rankin | Board of Directors | 0 companies |
| Bengt Staffan Lindstrand | Board of Directors | 0 companies |
| Michael John Matly | Board of Directors | 0 companies |
| Michael John Malty | Board of Directors | 0 companies |